Post-traumatic plasminogenesis in intraarticular exudate in the knee joint

Medical Science Monitor

Volumn 8, Issue 5, 2002, Pages

  Rość, Danuta ^a   Powierza, Wojciech ^a   Zastawna, Ewa ^a   Drewniak, Wanda ^a   Michalski, Arkadiusz ^a   Kotschy, Maria ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Exudate; Knee joint; Plasmin; Trauma

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTIPLASMIN; BETA GLOBULIN; COMPLEMENT COMPONENT C1S INHIBITOR; PLASMIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PREKALLIKREIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXUDATE; FEMALE; FIBRINOLYSIS; HUMAN; KNEE INJURY; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; SYNOVIAL FLUID LEVEL;

ADOLESCENT; ADULT; AGED; ANTIPLASMIN; COMPLEMENT C1 INACTIVATOR PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXUDATES AND TRANSUDATES; FEMALE; HUMANS; JOINT DISEASES; KNEE INJURIES; KNEE JOINT; MALE; MIDDLE AGED; PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN INACTIVATORS; SYNOVIAL FLUID; TIME FACTORS; URINARY PLASMINOGEN ACTIVATOR;

EID: 0242366535     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Knee joint traumas in the material of the orthopedic department at the regional Ambulance Service station in Bydgoszcz
2. Current views concerning management of post-traumatic lesions in the knee joint
3. Diagnostics and treatment of knee joint exudate in athletes
4. Knee joint meniscus damage in athletes
5. Membrane properties and esterase activity of synovial lining cells: Further evidence for mononuclear phagocyte subpopulation
6. Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases
7. Degradation of human articular cartilage by neutrophils in synovial fluid
8. Human synovial fibroblasts produce urokinase- type plasminogen activator
9. Greenberg ChS: Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthrtitis
10. Coagulation abnormalities in malignancy. A review
11. Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1) in diabetic angiopathy
12. Assessment of coagulation and fibrinolysis in synovial fluid of rheumatoid patients
13. Studies of the metabolism and distribution of fibrinogen in patients with rheumatoid arthritis
14. Fibrinolytic and fibrin stabilizing activity of synovial membranes
15. Fibrinolytic activity in rehumatoid arthritis and the effects of prednisolone therapy
16. Fibrin and fibronectin in rheumatoid synovial membrane and rheumatoid synovial fluid
17. The origin of fibrinogen, megakaryocytes and platelets
18. The urokinase receptor: Protein structure and role in plasminogen activation and cancer invasion
19. Advances in intravascular fibrinolysis activation diagnostics
20. Direct evidence for systemic fibrinogenolysis in a patients with metastatic prostatic cancer
21. Increase in levels of plasminogen activator and type-1 plasminogen activators inhibitor in human breast cancer. Possible role in tumor progression and metastasis
22. Elevated plasma levels ofalfa-2- antiplasmin inhibitor complex in patients with rheumatic diseases
23. Quantification of haemostatic proteins and activation products in synovial fluids from arthritic joints prior to and after induction of chemical synoviorthesis
24. Untersuchungen uber die gewebstandige plasminogenaktivator und plasmininhibitiraktivitat von gelenkkapseln bei verschidenen gelenerkrankungen
25. Fibrinolysis
26. Depression of tissue-type plasminogen activator and enhancement of urokinase- type plasminogen activator as an expression of local inflammation
27. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis
28. Effects of tumor necrosis factor alfa and beta on resorption of human articular cartilage and production of plasminogen activator by human articular chondrocytes
29. Human synovial fibroblasts produce urokinase- type plasiminogen activator
30. Increased Increased protcolytic activity on the surface of monocytes from patients with rheumatoid arthritis
31. The regulation ofhuman factor XIIa by plasma proteinase inhibitors
32. Interaction of 1125 lebelled complement subcomponents Clr and Cls with protease inhibitors in plasma
33. Relative contribution of contact and complement activation to inflammatory reactions in arthritic joints
34. Inactivation of human plasma C1-inhibitor by human PMN leucocyte matrix metalloproteinases